News

Researchers at the University of Würzburg in Bavaria, Germany, are focusing their psoriasis research on a cell type that has received little attention in connection with the skin disease: B lymphocytes.

The trend toward smaller biopsies may compromise the accuracy of dermatopathologists' diagnoses.

Hair loss after hair dyeing is common due to the manipulation of the hair shafts during the dyeing procedure.

Many dietary supplements have entered the market to support increased hair growth

It appears that patients with long hair are more often concerned about hair loss.

A new study suggests that insurance coverage of biologics for psoriasis is becoming more challenging. The need for prior authorization is increasing, as are the average time from prior authorization submission to coverage decisions and prior authorization denial rates.

Looks like marketing and publicity might have outpaced the validity and usefulness of a test used to detect Lyme disease.

Key resources for patients, families and healthcare providers who deal with alopecia areata include the National Alopecia Areata Foundation, the Children's Alopecia Project and the American Academy of Dermatology.

American Ninja Warrior competitor Kevin Bull is helping to boost awareness about alopecia areata, while researchers are beginning to tap the potential of JAK inhibitors for this indication.

Blogging is a very well respected and effective form of marketing that resonates with today’s internet-savvy, relationship-based consumers (i.e. patients). Here's why you should be blogging and how to get started.

The role of dermoscopy has expanded beyond melanoma detection. Experts offer best practices and explain how to embrace and use this powerful tool to get more complete and accurate diagnoses.

We asked you what your key challenges have been this year. These are your top-of-mind concerns.

There can often be delays in identifying SCARs and related conditions like TEN and SJS. The optimal management of these presentations involves multidisciplinary care.

MIPS will replace the Physician Quality Reporting System (PQRS) and CMS will adjust Medicare payments to most physicians either up or down by as much as 9% depending on how well they score in four performance categories. One expert shares insight based on a recent article published in JAMA Forum.

Researchers have uncovered new pathways that control skin lightening and tanning, which could lead to a novel class of therapeutics for treating pigmentation disorders.

Some unconventional therapies for rosacea get to the root of the problem, with apparent positive impacts on inflammation, skin barrier dysfunction and vascular function.

A seasoned dermatologist shares his views about dermatologists being overpaid, when to treat and when not to treat, and how best to stay informed.

Researchers report on survey findings that shed light on why patients find acne consultations ineffective.

Researchers reveal that patients may have concerns with acne consultations. The authors offer tips to improve acne consults.

Acne presents with certain nuances in darker skin patients. Exacerbating factors, treatment approaches and desired treatment outcomes may differ from lighter skin patients.

Security and encryption are key elements of a protocol for using a smart phone to take clinical pictures. Without those, dermatologists risk heavy fines and more.

Among the HIPAA secured platforms that can be used for photo sharing via secure messages is Doximity. The platform’s messaging is HIPAA-secure, and this is how.

Education is crucial for protecting yourself from possible misconduct from financial advisors. Recognizing these red flags can help you choose wisely and avoid mistakes.

This is an interesting and credible study of infants, suggesting there probably is a link, one expert notes. It remains to be seen whether water softeners and chlorine filters should be recommended one day. Read more on the data.

Pfizer and Anacor Pharmaceuticals announced in May that the pharmaceutical companies merged with Pfizer acquiring Anacor for about $5.2 billion. Dermatologists say merger is a good move for patients.

The investigational sebum-inhibiting topical DRM01 had positive results in a phase 2b study, which paves the way for phase 3 trials planned for 2017.

Results indicate an investigational topical anticholinergic product in development for patients with primary axillary hyperhidrosis may offer patients an effective new treatment option if approved.

EWG, which focuses on consumer and environmental health, claims that 72 percent of 750 available sunscreens the group evaluated offer inferior protection or contain ingredients that could harm skin. Some pediatric dermatologists weigh in.

Regulations surrounding electronic health records are evolving. The medical community waits hopefully for a system that focuses more on outcomes and less on the use of technology itself.

To establish and maintain a professional medical image in social media, pay careful attention to the content of posts. Be aware that social media content is admissible as evidence in courts of law.